Emmaus Life Sciences, Inc.
EMMA
$0.01
$0.00-1.02%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 293.00K | 886.00K | 1.33M | 1.39M | 1.26M |
| Total Receivables | 2.62M | 2.07M | 2.06M | 2.62M | 4.99M |
| Inventory | 1.21M | 1.31M | 1.44M | 1.64M | 1.61M |
| Prepaid Expenses | 346.00K | 525.00K | 611.00K | 894.00K | 530.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 315.00K | 220.00K | 211.00K | 226.00K | 817.00K |
| Total Current Assets | 4.79M | 5.02M | 5.65M | 6.77M | 9.20M |
|
|
|||||
| Total Current Assets | 4.79M | 5.02M | 5.65M | 6.77M | 9.20M |
| Net Property, Plant & Equipment | 927.00K | 973.00K | 1.37M | 1.58M | 1.77M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 167.00K | 168.00K | 222.00K | 222.00K | 312.00K |
| Total Assets | 20.76M | 23.34M | 22.48M | 23.60M | 27.34M |
|
|
|||||
| Total Accounts Payable | 724.00K | 750.00K | 520.00K | 594.00K | 578.00K |
| Total Accrued Expenses | 24.54M | 21.62M | 22.89M | 21.32M | 22.63M |
| Short-term Debt | 10.77M | 11.40M | 10.64M | 10.47M | 10.69M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.15M | 17.15M | 19.54M | 19.44M | 18.53M |
| Total Finance Division Other Current Liabilities | 10.99M | 11.15M | 11.32M | 11.74M | 11.70M |
| Total Other Current Liabilities | 10.99M | 11.15M | 11.32M | 11.74M | 11.70M |
| Total Current Liabilities | 64.17M | 62.08M | 64.92M | 63.56M | 64.13M |
|
|
|||||
| Total Current Liabilities | 64.17M | 62.08M | 64.92M | 63.56M | 64.13M |
| Long-Term Debt | 2.26M | 2.26M | 2.25M | 2.25M | 2.24M |
| Short-term Debt | 10.77M | 11.40M | 10.64M | 10.47M | 10.69M |
| Capital Leases | 1.50M | 1.58M | 544.00K | 815.00K | 1.08M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.31M | 13.13M | 13.37M | 13.47M | 13.68M |
| Total Liabilities | 80.24M | 79.05M | 81.08M | 80.08M | 81.12M |
|
|
|||||
| Common Stock & APIC | 225.98M | 225.97M | 225.97M | 225.96M | 225.93M |
| Retained Earnings | -268.12M | -266.04M | -264.91M | -262.58M | -260.83M |
| Treasury Stock & Other | -17.35M | -15.63M | -19.67M | -19.86M | -18.89M |
| Total Common Equity | -59.49M | -55.70M | -58.60M | -56.48M | -53.78M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -59.49M | -55.70M | -58.60M | -56.48M | -53.78M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -59.49M | -55.70M | -58.60M | -56.48M | -53.78M |
|
|
|||||